Table 1.
Relationship between GNG4 expression and clinical parameters in TARGET database.
| Variable | Number of patients | GNG4 expression | ||
|---|---|---|---|---|
| Low | High | P value | ||
| (N=42) | (N=42) | |||
| Age | 0.5027 | |||
| >16 years | 33 (39.3%) | 18 (42.9%) | 15(35.7%) | |
| ≤16 years | 51 (60.7%) | 24(57.1%) | 27 (64.3%) | |
| Gender | 0.826 | |||
| Female | 37 (44.0%) | 19 (45.2%) | 18(42.9%) | |
| Male | 47(56.0%) | 23 (54.8%) | 24 (57.1%) | |
| Relapse | 0.0002 | |||
| No | 31 (44.9%) | 22(68.8%) | 9 (24.3%) | |
| Yes | 38 (55.1%) | 10 (31.2%) | 28(75.7%) | |
| Metastasis | 0.8011 | |||
| No | 63 (75.0%) | 31 (73.8%) | 32 (76.2%) | |
| Yes | 21 (25.0%) | 11 (26.2%) | 10 (23.8%) | |
| Site | >0.9999 | |||
| Arm/Hand | 6 (7.1%) | 3 (7.1%) | 3 (7.1%) | |
| Leg/Foot | 76 (90.5%) | 38 (90.5%) | 38 (90.5%) | |
| Pelvis | 2 (2.4%) | 1 (2.4%) | 1 (2.4%) | |
Values in bold indicate a P value less than 0.05, indicating a statistically significant difference.